202 related articles for article (PubMed ID: 31728681)
21. Critical Appraisal of Advanced Glycation End Products (AGEs) and Circulating Soluble Receptors for Advanced Glycation End Products (sRAGE) as a Predictive Biomarkers for Cardiovascular Disease in Hemodialysis Patients.
Assiri AMA; Kamel HFM; ALrefai AA
Med Sci (Basel); 2018 May; 6(2):. PubMed ID: 29789493
[TBL] [Abstract][Full Text] [Related]
22. Soluble receptor for advanced glycation end products and lipid profile ratio as cardiovascular risk markers in children with obesity.
Flores-Ramírez AG; Ibarra-Reynoso LDR; Garay-Sevilla ME
Gac Med Mex; 2023; 159(1):10-16. PubMed ID: 36930549
[TBL] [Abstract][Full Text] [Related]
23. Enhanced expression of receptor for advanced glycation end-products is associated with low circulating soluble isoforms of the receptor in Type 2 diabetes.
Tam XH; Shiu SW; Leng L; Bucala R; Betteridge DJ; Tan KC
Clin Sci (Lond); 2011 Jan; 120(2):81-9. PubMed ID: 20726839
[TBL] [Abstract][Full Text] [Related]
24. Plasma glycation adducts and various RAGE isoforms are intricately associated with oxidative stress and inflammatory markers in type 2 diabetes patients with vascular complications.
Adeshara KA; Bangar N; Diwan AG; Tupe RS
Diabetes Metab Syndr; 2022 Mar; 16(3):102441. PubMed ID: 35247657
[TBL] [Abstract][Full Text] [Related]
25. Oligofructose-enriched inulin improves some inflammatory markers and metabolic endotoxemia in women with type 2 diabetes mellitus: a randomized controlled clinical trial.
Dehghan P; Pourghassem Gargari B; Asghari Jafar-abadi M
Nutrition; 2014 Apr; 30(4):418-23. PubMed ID: 24332524
[TBL] [Abstract][Full Text] [Related]
26. Action of metformin therapy against advanced glycation, oxidative stress and inflammation in type 2 diabetes patients: 3 months follow-up study.
Adeshara KA; Bangar NS; Doshi PR; Diwan A; Tupe RS
Diabetes Metab Syndr; 2020; 14(5):1449-1458. PubMed ID: 32769032
[TBL] [Abstract][Full Text] [Related]
27. Changes in circulating levels of carboxymethyllysine, soluble receptor for advanced glycation end products (sRAGE), and inflammation markers in women during normal pregnancy.
Quintanilla-García CV; Uribarri J; Fajardo-Araujo ME; Barrientos-Romero JJ; Romero-Gutiérrez G; Reynaga-Ornelas MG; Garay-Sevilla ME
J Matern Fetal Neonatal Med; 2019 Dec; 32(24):4102-4107. PubMed ID: 29804482
[No Abstract] [Full Text] [Related]
28. Altered expression of a disintegrin and metalloproteinase 10 in peripheral blood mononuclear cells in type 2 diabetes mellitus patients with the acute coronary syndrome: a pilot study.
Ragavi R; Adole PS; Vinod KV; Pillai AA
Endocrine; 2022 Sep; 77(3):461-468. PubMed ID: 35877008
[TBL] [Abstract][Full Text] [Related]
29. Modulation of high sensitivity C-reactive protein by soluble receptor for advanced glycation end products.
McNair ED; Wells CR; Mabood Qureshi A; Basran R; Pearce C; Orvold J; Devilliers J; Prasad K
Mol Cell Biochem; 2010 Aug; 341(1-2):135-8. PubMed ID: 20339904
[TBL] [Abstract][Full Text] [Related]
30. Plasma Levels of Pentosidine, Carboxymethyl-Lysine, Soluble Receptor for Advanced Glycation End Products, and Metabolic Syndrome: The Metformin Effect.
Haddad M; Knani I; Bouzidi H; Berriche O; Hammami M; Kerkeni M
Dis Markers; 2016; 2016():6248264. PubMed ID: 27829696
[TBL] [Abstract][Full Text] [Related]
31. Higher levels of the soluble receptor for advanced glycation end products and lower levels of the extracellular newly identified receptor for advanced glycation end products were associated with lipid-lowering drugs in patients with type 1 diabetes: a comparative cross-sectional study.
Melin EO; Dereke J; Hillman M
Lipids Health Dis; 2020 Oct; 19(1):223. PubMed ID: 33054750
[TBL] [Abstract][Full Text] [Related]
32. Reduced soluble receptor for advanced glycation end-products (sRAGE) scavenger capacity precedes pre-eclampsia in Type 1 diabetes.
Yu Y; Hanssen KF; Kalyanaraman V; Chirindel A; Jenkins AJ; Nankervis AJ; Torjesen PA; Scholz H; Henriksen T; Lorentzen B; Garg SK; Menard MK; Hammad SM; Scardo JA; Stanley JR; Wu M; Basu A; Aston CE; Lyons TJ
BJOG; 2012 Nov; 119(12):1512-20. PubMed ID: 22900949
[TBL] [Abstract][Full Text] [Related]
33. Omega 3-rich Camelina sativa oil in the context of a weight loss program improves glucose homeostasis, inflammation and oxidative stress in patients with NAFLD: A randomised placebo-controlled clinical trial.
Musazadeh V; Dehghan P; Saleh-Ghadimi S; Abbasalizad Farhangi M
Int J Clin Pract; 2021 Nov; 75(11):e14744. PubMed ID: 34423525
[TBL] [Abstract][Full Text] [Related]
34. Hepatic Fat Content and Liver Enzymes Are Associated with Circulating Free and Protein-Bound Advanced Glycation End Products, Which Are Associated with Low-Grade Inflammation: The CODAM Study.
Bijnen M; van Greevenbroek MMJ; van der Kallen CJH; Scheijen JL; van de Waarenburg MPH; Stehouwer CDA; Wouters K; Schalkwijk CG
J Diabetes Res; 2019; 2019():6289831. PubMed ID: 31218233
[TBL] [Abstract][Full Text] [Related]
35. Soluble receptor for advanced glycation end products is associated with in-stent restenosis in patients with type 2 diabetes with drug-eluting coronary stents.
Park HJ; Seo SM; Shin WS; Kim HY; Choi YS; Koh YS; Youn SG; Park MW; Chang K; Kim PJ; Jung HO; Baek SH; Chung WS; Seung KB; Yoo KD
Coron Artery Dis; 2011 Jan; 22(1):12-7. PubMed ID: 21197704
[TBL] [Abstract][Full Text] [Related]
36. Soluble Receptor for Advanced Glycation End Products and Its Correlation with Vascular Damage in Adolescents with Obesity.
Rodríguez-Mortera R; Luevano-Contreras C; Solorio-Meza S; Gómez-Ojeda A; Caccavello R; Bains Y; Gugliucci A; Garay-Sevilla ME
Horm Res Paediatr; 2019; 92(1):28-35. PubMed ID: 31412337
[TBL] [Abstract][Full Text] [Related]
37. Is there any place for resistant starch, as alimentary prebiotic, for patients with type 2 diabetes?
Gargari BP; Namazi N; Khalili M; Sarmadi B; Jafarabadi MA; Dehghan P
Complement Ther Med; 2015 Dec; 23(6):810-5. PubMed ID: 26645521
[TBL] [Abstract][Full Text] [Related]
38. Divergent Changes in Plasma AGEs and sRAGE Isoforms Following an Overnight Fast in T1DM.
Miranda ER; Fuller KNZ; Perkins RK; Beisswenger PJ; Farabi SS; Quinn L; Haus JM
Nutrients; 2019 Feb; 11(2):. PubMed ID: 30781793
[TBL] [Abstract][Full Text] [Related]
39. A Combination of Prebiotic Inulin and Oligofructose Improve Some of Cardiovascular Disease Risk Factors in Women with Type 2 Diabetes: A Randomized Controlled Clinical Trial.
Aliasgharzadeh A; Khalili M; Mirtaheri E; Pourghassem Gargari B; Tavakoli F; Abbasalizad Farhangi M; Babaei H; Dehghan P
Adv Pharm Bull; 2015 Nov; 5(4):507-14. PubMed ID: 26819923
[TBL] [Abstract][Full Text] [Related]
40. Accumulation of advanced glycation end products (AGEs) is associated with the severity of aortic stenosis in patients with concomitant type 2 diabetes.
Kopytek M; Ząbczyk M; Mazur P; Undas A; Natorska J
Cardiovasc Diabetol; 2020 Jun; 19(1):92. PubMed ID: 32552684
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
